All
 
|
 
 


“Compulsory” immune response: challenges of vaccination against COVID-19 (The end)
 
PIIS102694520020477-5-1
DOI10.31857/S102694520020477-5
Publication type Article
Status Published
Authors
Alexandra A. Troitskaya 
Occupation: associate Professor of the Constitutional and Municipal Law Department
Affiliation: Faculty of Law at Lomonosov Moscow state University
Address: Russian Federation,
Tatiana M. Khramova
Occupation: associate Professor of the Public Law Department of the Law Faculty
Affiliation: National Research University “Higher School of Economics”
Address: Russian Federation
Journal nameGosudarstvo i pravo
EditionIssue 6
Pages109-121
Abstract

The article adopts an interdisciplinary approach to reflecting the challenges of immunization against COVID-19: it reveals both medical and legal concerns that accompany the current vaccination model in Russia and characterize this model as unbalanced. On the one hand, the authors underline the advantages of vaccination as opposed to alternative means to address the current pandemic. On the other hand, they stipulate the risks associated primarily with the high level of uncertainty of both medical and legal parameters of the vaccination scheme adopted in Russia. The authors consequently analyze a number of medical findings on efficacy and security of the existing vaccines and conduct the proportionality test of current legal regulation that guides vaccination against COVID-19 in Russia. The article concludes with an observation that a well-balanced model of regulation should be based on high-quality research findings and be accompanied by the willingness of the state to carry out a consistent information campaign and take on the responsibility for negative side-effects experienced by some citizens who have gone through vaccination.

Keywordsvaccination, compulsory vaccination, COVID-19 pandemic, proportionality
Received28.10.2021
Publication date20.06.2022
Number of characters52313
Cite  
100 rub.
When subscribing to an article or issue, the user can download PDF, evaluate the publication or contact the author. Need to register.

Number of purchasers: 0, views: 440

Readers community rating: votes 0 

1. Dolzhikov A. Is it time to understand Russia with your mind? The requirement of fitness in constitutional justice // Comparative Constitutional Review. 2020. No. 6 (139). P. 56 (in Russ.).
2. Markova E. Mandatory vaccination in the conditions of the COVID-19 pandemic // Journal of the Belarusian State University. Law. 2020. No. 3. P. 40 (in Russ.).
3. Markova E.N. The right to refuse compulsory vaccination in accordance with religious beliefs: pro et contra // State power and local self-government. 2019. No. 2. P. 6 (in Russ.).
4. Ryzhikov A.B., Ryzhikov E.A., Bogryantseva M.P. and others. A simple blind placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the EpiVacCorona vaccine for the prevention of COVID-19 on volunteers aged 18-60 years (phase I–II) // Infection and immunity. 2021. No. 2. P. 283 - 296 (in Russ.).
5. Aditya, A. and Jiao, C. Indonesia to Punish Those Who Refuse to Take Covid-19 Vaccine. URL: https://www.bloomberg.com/news/articles/2021-02-18/indonesia-to-punish-those-who-refuse-to-take-covid-19-vaccine?sref=yLCixKPR 
6. Albin E., Gross A. First In First Out: The Rise and Fall of Israel’s Green Pass. URL: https://lexatlas-c19.org/first-in-first-out-the-rise-and-fall-of-israels-green-pass/ 
7. Albin E., Gross A., Luster T. Rise Like a Phoenix: The Return of Israel’s Green Pass – Questions of Domestic and Global Health Justice. URL: https://lexatlas-c19.org/rise-like-a-phoenix-the-return-of-israels-green-pass-questions-of-domestic-and-global-health-justice/ 
8. Barak A. Proportionality: constitutional rights and their limitations. Cambridge; N.Y., 2012. P. 131, 308, 309.
9. Cameron I., and Cornell, A. J. Countering the Spread of COVID-19 by means of Recommendations // IACL-AIDC Blog, 14 September 2021. URL: https://blog-iacl-aidc.org/covid19-future-constitutionalism/2021/9/14/countering-the-spread-of-covid-19-by-means-of-recommendations-and-its-constitutional-implications-y6yds 
10. Corbet S. France’s virus pass now required in restaurants, trains // AP News, 9 August 2021. URL: https://apnews.com/article/europe-business-health-france-coronavirus-pandemic-655d8451d7494f8663ce2072e64cf7a6 
11. Douglas T. There is no fundamental ethical objection to vaccine passports. The Brussels Times, 27 February 2021. URL: https://www.brusselstimes.com/opinion/157297/there-is-no-fundamental-ethical-objection-to-vaccine-passports/ 
12. Dyer O. Covid-19: Turkmenistan becomes first country to make vaccination mandatory for all adults // BMJ 2021, 374. URL: https://www.bmj.com/content/374/bmj.n1766 
13. Ford M. Covid-19 vaccines to be made mandatory for all care home staff in England // Nursing Times, 16 June 2021. URL: https://www.nursingtimes.net/news/social-care/covid-19-vaccines-to-be-made-mandatory-for-all-care-home-staff-in-england-16-06-2021/ 
14. Gomes de Matos A.A., Cardoso G.P., Rolim Neto M.L. Sputnik V: Is the Russian Vaccine Safe? // Clinics in Surgery. 2021. No 6. Art. 3265.
15. Gushchin V.A., Dolzhikova I.V., Shchetinin A.M. et al. Neutralizing Activity of Sera from Sputnik V-Vaccinated People against Variants of Concern (VOC: B.1.1.7, B.1.351, P.1, B.1.617.2, B.1.617.3) and Moscow Endemic SARS-CoV-2 Variants // Vaccines. 2021. No. 9. P. 779.
16. Kimberly A. Prather, Chia C. Wang and Robert T. Schooley. Reducing transmission of SARS-CoV-2 // Science, 26 Jun 2020. Vol. 368. No. 6498. P. 1422–1424. URL: https://www.science.org/doi/10.1126/science.abc6197 
17. Kozlovskaya L.I., Piniaeva A.N., Ignatyev G.M. et al. Long-term humoral immunogenicity, safety and protective efficacy of inactivated vaccine against Covid-19 (CoviVac) in preclinical studies // Emerging Microbes & Infections. 2021. Vol 10. No. 1. P. 1790–1806.
18. Krasser A. Compulsory Vaccination in a Fundamental Rights Perspective: Lessons from the ECtHR // ICL Journal. Vol. 15. 2021. No. 2. P. 208, 216.
19. Logunov D.Y., Dolzhikova I.V., Shcheblyakov D.V. et al. Safety and efficacy of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine: an interim analysis of a randomised controlled phase 3 trial in Russia // The Lancet. 2021 (February). P. 671 - 681.
20. Logunov D.Y., Dolzhikova I.V., Zubkova O.V. et al. Safety and immunogenicity of an rAd26 and rAd5 vector-based heterologous prime-boost COVID-19 vaccine in two formulations: two open, non-randomised phase 1/2 studies from Russia // The Lancet. 2020 (September). P. 887–897.

Система Orphus

Loading...
Up